-

07:23:32 PM

PACB Stock News

PACB - Pacific Biosciences of California Inc

01/24/23 11:18 PM

Nasdaq : PACB

offering

Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock

Pacific Biosciences of California, Inc. today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock at a price to the public of $10.00 per share. Goldman Sachs& Co. LLC, Morgan Stanley& Co. LLC, Cowen and Company, LLC and Allen& Company LLC are acting as Joint Book Running managers for the...

RHEA-AI

neutral

01/24/23 4:05 PM

Nasdaq : PACB

offering

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a

RHEA-AI

neutral

01/13/23 10:04 AM

Nasdaq : PACB

PacBio Celebrates Nature Methods Naming Long-Read Sequencing "Method of the Year"

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today celebrated long-read sequencing being named Nature Methods' "Method of the Year 2022." Nature Methods had recognized the impact of long-read sequencing in a variety of groundbreaking studies, including those leveraging PacBio technology from the Vertebrate Genome...

RHEA-AI

neutral

01/09/23 7:05 AM

Nasdaq : PACB

PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced

RHEA-AI

positive

01/09/23 7:00 AM

Nasdaq : PACB

PacBio and the University of Tokyo Announce Bioinformatics Applications Collaboration

PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a collaboration with the University of Tokyo, Graduate School of Medicine to study the use of long-read sequencing and novel bioinformatics methods

RHEA-AI

neutral

12/28/22 4:05 PM

Nasdaq : PACB

conferences

PacBio to Present at 41st Annual J.P. Morgan Healthcare Conference

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the following events at the 41st Annual J.P. Morgan Healthcare Conference:Panel | Multiomics:

RHEA-AI

neutral

12/06/22 9:05 AM

Nasdaq : PACB

PacBio and Boston Children's Hospital Collaborate to Investigate Novel Variants Inaccessible by Short-Read Sequencing

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its HiFi sequencing technology will be used in a pilot project for

RHEA-AI

neutral

11/11/22 4:05 PM

Nasdaq : PACB

conferences

PacBio to Present at Upcoming Investor Conferences

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the following upcoming investor conferences:Canaccord Genuity MedTech, Diagnostics and Digital

RHEA-AI

neutral

11/07/22 4:05 PM

Nasdaq : PACB

earnings

PacBio Announces Third Quarter 2022 Financial Results

PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2022.Third quarter resultsRevenue of $32.3 million, a 7% decrease compared with $34.9 million in the prior year period. Instrument revenue of $11.4

RHEA-AI

neutral

11/02/22 9:05 AM

Nasdaq : PACB

management

PacBio Announces that Euan Ashley, M.D., Ph.D., Joseph Puglisi, Ph.D., and Jay Shendure, Ph.D., Join Newly Created Scientific Advisory Board

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it is bringing together

RHEA-AI

very positive

1 2 3 4 5 6 7 8 9 10 Next

PACB Data

IndustryAnalytical Laboratory Instrument Manufacturing
Websitewww.pacb.com
Security namePacific Biosciences of California Inc
Issue typecs
SectorManufacturing
Sic code3826
Employees728
Tags
- Health Technology
- Biotechnology
- Manufacturing
- Analytical Laboratory Instrument Manufacturing

About Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.